Annual report pursuant to Section 13 and 15(d)

Cash, Cash Equivalents and Short-Term Investments (Tables)

v3.22.4
Cash, Cash Equivalents and Short-Term Investments (Tables)
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash were as follows (in millions):
As of
December 31,
2022		 December 31,
2021
Cash and cash equivalents $ 262  $ 1,610 
Restricted cash, long-term (a)
15  16 
Total cash, cash equivalents and restricted cash
 $ 277  $ 1,626 
(a) Included in Other assets on the consolidated balance sheets
Schedule of Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash were as follows (in millions):
As of
December 31,
2022		 December 31,
2021
Cash and cash equivalents $ 262  $ 1,610 
Restricted cash, long-term (a)
15  16 
Total cash, cash equivalents and restricted cash
 $ 277  $ 1,626 
(a) Included in Other assets on the consolidated balance sheets
Schedule of Fair Value, Assets Measured on Recurring Basis
The components of cash equivalents and short-term investments measured at fair value on a recurring basis were as follows (in millions):
As of
Fair value level December 31,
2022		 December 31,
2021
Cash equivalents:
Money market funds
 Level 1 $ 204  $ 1,610 
U.S. Treasury securities
 Level 2 57  — 
Total cash equivalents
 $ 261  $ 1,610 
Short-term investments:
U.S. Treasury securities
 Level 2 $ 839  $ — 
Total short-term investments $ 839  $ — 
Schedule of U.S Treasury Securities , Amortized Costs and Fair Value
The amortized cost, unrealized gains and losses, and fair value of available-for-sale debt securities were as follows (in millions):
As of December 31, 2022
Amortized cost Unrealized losses Fair value
U.S. Treasury securities $ 841  $ (2) $ 839